This study analyzes trends in testosterone therapy prescriptions for women with hypoactive sexual desire disorder (HSDD) and reveals that while testosterone prescriptions have increased, there is a considerable underprescription and variability in treatment types. It also highlights the coadministration of testosterone with estrogen. The study was based on a cohort
